Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilazodone for relapse prevention in major depressive disorder
NCT01573598Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Apr 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of vilazodone in major depressive disorder (MDD), sponsored by Forest Laboratories. Started Apr 2012; status: completed.
02
Drugs
vilazodone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01573598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01573598.